BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16939433)

  • 1. The future of atrial fibrillation therapy.
    Dorian P
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S11-6. PubMed ID: 16939433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of atrial fibrillation: state of the art.
    Camm J
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S2-6. PubMed ID: 16939435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy for atrial fibrillation: what will its role be in the era of increasing use of catheter ablation?
    Morrow JP; Reiffel JA
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):108-18. PubMed ID: 19140921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of rhythm and rate control in patients with atrial fibrillation.
    Prystowsky EN
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S7-10. PubMed ID: 16939436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.
    Govindan M; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):210-21. PubMed ID: 18806601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?
    Slavik RS; Zed PJ
    Pharmacotherapy; 2004 Jun; 24(6):792-8. PubMed ID: 15222670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
    Naccarelli GV; Gonzalez MD
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):203-9. PubMed ID: 18806600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation: cure or treat?
    Forleo GB; Tondo C
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):187-96. PubMed ID: 19443515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
    Le Heuzey JY; Breithardt G; Camm J; Crijns H; Dorian P; Kowey PR; Merioua I; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
    Am J Cardiol; 2010 Mar; 105(5):687-93. PubMed ID: 20185018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation-the final frontier.
    Govindan M; Savelieva I; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):36S-50S. PubMed ID: 20940451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology, pathophysiology, and treatment of atrial fibrillation: part 1.
    Aronow WS
    Cardiol Rev; 2008; 16(4):181-8. PubMed ID: 18562808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional management of atrial fibrillation.
    Arora S; Mookadam F; Srivathsan K
    Expert Rev Cardiovasc Ther; 2010 Jul; 8(7):949-58. PubMed ID: 20602556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation.
    Fang MC; Stafford RS; Ruskin JN; Singer DE
    Arch Intern Med; 2004 Jan; 164(1):55-60. PubMed ID: 14718322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.